mhurhangee/patent-ind-claim-en huggingface dataset:
A distance measuring device comprising: a light emission portion configured to emit light; a light receiving portion configured to receive measurement light that is emitted by the light emission portion and reflected by a measurement object , the light receiving portion comprising a plurality of pixels , each pixel having at least one light receiving portion and being configured to output a light reception signal (RS1) that depends on the measurement light incident on the pixel ; a discrimination portion configured to discriminate whether the pixel receives measurement light or ambient light only and to output a discrimination result (DR) indicating whether the light received by the pixel includes measurement light or ambient light only; a pixel output control portion configured to selectively output the light reception signal (RS2) of each pixel individually, depending on the discrimination result (DR) of the discrimination portion ; and an evaluation portion configured to receive the light reception signals (RS2) output by the pixel output control portion and to output a distance signal that is indicative of a distance between the measuring device and the measurement object , based on these light reception signals (RS2), wherein the pixel output control portion is configured to output the light reception signal (RS2) of those pixels for which the discrimination portion determines that measurement light is received. a light emission portion configured to emit light; a light receiving portion configured to receive measurement light that is emitted by the light emission portion and reflected by a measurement object , the light receiving portion comprising a plurality of pixels , each pixel having at least one light receiving portion and being configured to output a light reception signal (RS1) that depends on the measurement light incident on the pixel ; a discrimination portion configured to discriminate whether the pixel receives measurement light or ambient light only and to output a discrimination result (DR) indicating whether the light received by the pixel includes measurement light or ambient light only; a pixel output control portion configured to selectively output the light reception signal (RS2) of each pixel individually, depending on the discrimination result (DR) of the discrimination portion ; and an evaluation portion configured to receive the light reception signals (RS2) output by the pixel output control portion and to output a distance signal that is indicative of a distance between the measuring device and the measurement object , based on these light reception signals (RS2), wherein the pixel output control portion is configured to output the light reception signal (RS2) of those pixels for which the discrimination portion determines that measurement light is received.
A linear actuator including: a cylinder defining a cylinder axis ; a piston movable within the cylinder along the cylinder axis ; a piston rod extending axially from the piston for connection to a mechanism whereby in use, movement of the piston actuates the mechanism; a rotary output mechanism including a rotary output element extending generally transversely from the cylinder and supported for rotation about an output axis generally normal to the cylinder axis ; the rotary output mechanism being responsive to movement of the piston , and the rotary output element being adapted for operative engagement with an instrument mountable to the cylinder ; such that axial movement of the piston effects a corresponding rotational displacement of the rotary output element , whereby in use the instrument provides an output signal indicative of the position of the piston within the cylinder and the rotary output mechanism includes a scissor linkage mechanism , including a plurality of elongate linkage elements pivotably interconnected in a criss-cross configuration within the cylinder , with a pivot axis at each end, and characterized in that a swivel assembly is interposed between the scissor linkage mechanism and a crown of the piston , the swivel assembly enabling relative rotational displacement between the scissor linkage mechanism and the piston around the cylinder axis . a cylinder defining a cylinder axis ; a piston movable within the cylinder along the cylinder axis ; a piston rod extending axially from the piston for connection to a mechanism whereby in use, movement of the piston actuates the mechanism; a rotary output mechanism including a rotary output element extending generally transversely from the cylinder and supported for rotation about an output axis generally normal to the cylinder axis ; the rotary output mechanism being responsive to movement of the piston , and the rotary output element being adapted for operative engagement with an instrument mountable to the cylinder ; such that axial movement of the piston effects a corresponding rotational displacement of the rotary output element , whereby in use the instrument provides an output signal indicative of the position of the piston within the cylinder and the rotary output mechanism includes a scissor linkage mechanism , including a plurality of elongate linkage elements pivotably interconnected in a criss-cross configuration within the cylinder , with a pivot axis at each end, and characterized in that a swivel assembly is interposed between the scissor linkage mechanism and a crown of the piston , the swivel assembly enabling relative rotational displacement between the scissor linkage mechanism and the piston around the cylinder axis .
An intrathecal drug delivery system comprising: (a) a sterilised syringe with a leur-lock tip ; characterised in that (b) the sterilised syringe containing a sterile, stable solution consisting of baclofen, sodium chloride and water which has been formed aseptically and terminally sterilized and inserted into the sterilized syringe with minimal head space; (c) a color coding system on a label or plunger of the sterilised syringe indicative of various concentrations of baclofen of (b) or indicative of size of the sterilised syringe; and (d) instructions for use. (a) a sterilised syringe with a leur-lock tip ; characterised in that (b) the sterilised syringe containing a sterile, stable solution consisting of baclofen, sodium chloride and water which has been formed aseptically and terminally sterilized and inserted into the sterilized syringe with minimal head space; (c) a color coding system on a label or plunger of the sterilised syringe indicative of various concentrations of baclofen of (b) or indicative of size of the sterilised syringe; and (d) instructions for use.
A neutron detector, having a cylindrical detector housing with a circular or square section containing a translucent type plate neutron scintillator having a structure capable of emitting fluorescence from both faces, and two photo multipliers, one arranged on each end of the detector housing; whe rein said neutron scintillator is composed of a ZnS fluorescent substance and a neutron converter substance which contains 6 Li or 10 B, and is arranged at an angle of 45 degrees from the neutrons which are incident in parallel all together, within the detector housing a specular reflector with a reflectance of 90% or more is arranged, and wherein the two photo multipliers are configured to detect the fluorescence emitted when a neutron enters the scintillator, and to generate signals output capable of being processed to be taken out as a neutron signal. said neutron scintillator is composed of a ZnS fluorescent substance and a neutron converter substance which contains 6 Li or 10 B, and is arranged at an angle of 45 degrees from the neutrons which are incident in parallel all together, within the detector housing a specular reflector with a reflectance of 90% or more is arranged, and wherein the two photo multipliers are configured to detect the fluorescence emitted when a neutron enters the scintillator, and to generate signals output capable of being processed to be taken out as a neutron signal.
A reception apparatus comprising: a reception section configured to receive a physical layer frame transported as a broadcast signal, wherein the physical layer frame complies with a DVB-T2 (Digital Video Broadcasting - Terrestrial 2) standard; and a demodulation section configured to demodulate physical layer signaling acquired from the physical layer frame and monitor whether or not emergency warning information has been transported on a basis of emergency warning notice information acquired as a result of the demodulation, wherein the emergency warning information is assigned to RESERVED_2 bits in configurable L1-post signaling of the physical layer frame, wherein the reception apparatus is on standby and is configured to start up automatically in a case where the emergency warning notice information indicates that the emergency warning information has been transported and when characteristic information indicating characteristics of the emergency warning information acquired as the result of the demodulation of the physical layer signaling matches with predefined settings of the reception apparatus, wherein the characteristic information includes at least one of a version of the emergency warning information, a target country and a target region of the emergency warning information, or a disaster type indicated by details of the emergency warning information. a reception section configured to receive a physical layer frame transported as a broadcast signal, wherein the physical layer frame complies with a DVB-T2 (Digital Video Broadcasting - Terrestrial 2) standard; and a demodulation section configured to demodulate physical layer signaling acquired from the physical layer frame and monitor whether or not emergency warning information has been transported on a basis of emergency warning notice information acquired as a result of the demodulation, wherein the emergency warning information is assigned to RESERVED_2 bits in configurable L1-post signaling of the physical layer frame, demodulate physical layer signaling acquired from the physical layer frame and monitor whether or not emergency warning information has been transported on a basis of emergency warning notice information acquired as a result of the demodulation, wherein the emergency warning information is assigned to RESERVED_2 bits in configurable L1-post signaling of the physical layer frame, wherein the reception apparatus is on standby and is configured to start up automatically in a case where the emergency warning notice information indicates that the emergency warning information has been transported and when characteristic information indicating characteristics of the emergency warning information acquired as the result of the demodulation of the physical layer signaling matches with predefined settings of the reception apparatus, wherein the characteristic information includes at least one of a version of the emergency warning information, a target country and a target region of the emergency warning information, or a disaster type indicated by details of the emergency warning information.
A silicone hydrogel contact lens, comprising: a polymeric lens body that is the reaction product of a polymerizable composition, said polymerizable composition comprising: (a) at least one siloxane monomer; (b) ethylene glycol methyl ether methacrylate (EGMA) in an amount of from 1 to 20 unit parts by weight; and (c) methyl methacrylate (MMA) in an amount of from 5 to 25 unit parts by weight, wherein the ratio of unit parts by weight of MMA to unit parts by weight of EGMA present in the polymerizable composition is from about 6:1 to about 1:1. (a) at least one siloxane monomer; (b) ethylene glycol methyl ether methacrylate (EGMA) in an amount of from 1 to 20 unit parts by weight; and (c) methyl methacrylate (MMA) in an amount of from 5 to 25 unit parts by weight,
A recombinant DNA vaccine for use in a method of eliciting an anti-tumor response in a subject having prostate cancer, wherein the method comprises: a. administering to the subject androgen deprivation therapy (ADT); and b. administering to the subject said recombinant DNA vaccine wherein the recombinant DNA vaccine comprises a polynucleotide operably linked to a transcriptional regulatory element wherein the polynucleotide encodes an androgen receptor or a fragment of the androgen receptor selected from the group consisting of (i) a mammalian androgen receptor, (ii) the ligand-binding domain of the androgen receptor, (iii) a fragment of the ligand-binding domain defined by SEQ ID NO:9, (iv) a fragment of the ligand-binding domain defined by SEQ ID NO:10, (v) a fragment of the ligand-binding domain defined by SEQ ID NO:11, and (vi) a fragment of the ligand-binding domain defined by SEQ ID NO:12, wherein the recombinant DNA vaccine is administered in an amount effective to elicit an increased anti-tumor response to the prostate cancer, wherein the combination treatment of ADT and the recombinant DNA vaccine inhibits, delays or reduces the growth of the prostate cancer. a. administering to the subject androgen deprivation therapy (ADT); and b. administering to the subject said recombinant DNA vaccine wherein the recombinant DNA vaccine comprises a polynucleotide operably linked to a transcriptional regulatory element wherein the polynucleotide encodes an androgen receptor or a fragment of the androgen receptor selected from the group consisting of (i) a mammalian androgen receptor, (ii) the ligand-binding domain of the androgen receptor, (iii) a fragment of the ligand-binding domain defined by SEQ ID NO:9, (iv) a fragment of the ligand-binding domain defined by SEQ ID NO:10, (v) a fragment of the ligand-binding domain defined by SEQ ID NO:11, and (vi) a fragment of the ligand-binding domain defined by SEQ ID NO:12,
Antibody or antigen-binding fragment thereof that binds to the EDA domain of fibronectin-EDA, comprising a heavy chain variable region comprising: - a CDR1 having the amino acid sequence GYSITSGYSWH; - a CDR2 having the amino acid sequence YIHYSGX 1 ANYNPSLKS, and wherein X 1 is selected from S and I; and - a CDR3 having the amino acid sequence EKTGFFDY; and a light chain variable region comprising: - a CDR1 having the amino acid sequence RSSQSLVHSNGNTYLH; - a CDR2 having the amino acid sequence KVSNRFS; and - a CDR3 having the amino acid sequence SQSAHVPPT. - a CDR1 having the amino acid sequence GYSITSGYSWH; - a CDR2 having the amino acid sequence YIHYSGX 1 ANYNPSLKS, and wherein X 1 is selected from S and I; and - a CDR3 having the amino acid sequence EKTGFFDY; - a CDR1 having the amino acid sequence RSSQSLVHSNGNTYLH; - a CDR2 having the amino acid sequence KVSNRFS; and - a CDR3 having the amino acid sequence SQSAHVPPT.
Elementary cell (1; 1'; 1"; 10; 100; 100') made of acoustic metamaterial, comprising: - a body made of solid material (2; 2'; 2"; 20; 200; 200'), - at least one Fabry-Perot cavity (3; 3'; 3"; 30; 300; 300') in said body (2; 2'; 2"; 20; 200; 200'), and - at least one lateral resonant cavity (4; 4'; 4"; 41, 42, 43; 400; 400'), which is a Helmholtz acoustic resonator, and communicates with said Fabry-Perot cavity (3; 3'; 3"; 30; 300; 300'), characterized in that the Fabry-Perot cavity (3; 3'; 3"; 30; 300; 300') is a channel which passes through said body (2; 2'; 2"; 20; 200; 200'), and in that the Helmholtz resonator is a cylindrical cavity (4; 4'; 4"; 41, 42, 43; 400; 400') which is concentric with the through-channel (3; 3'; 3"; 30; 300; 300') and communicates with said channel (3; 3'; 3"; 30; 300; 300') via a neck (5; 5'; 5"; 50; 500; 500'). - a body made of solid material (2; 2'; 2"; 20; 200; 200'), - at least one Fabry-Perot cavity (3; 3'; 3"; 30; 300; 300') in said body (2; 2'; 2"; 20; 200; 200'), and - at least one lateral resonant cavity (4; 4'; 4"; 41, 42, 43; 400; 400'), which is a Helmholtz acoustic resonator, and communicates with said Fabry-Perot cavity (3; 3'; 3"; 30; 300; 300'),
A system for detecting breakage of a gas turbine shaft, comprising: a magnetic circuit , forming one or more closed loop paths containing a magnetic flux, comprising a first magnetic portion and a second portion , and including at least one air gap between the first portion and the second portion; characterised in that the system further comprises: a detection coil wound around the first magnetic portion, the first magnetic portion comprising a permanent magnet or an electromagnet; wherein, the second portion is coupled to or moveable with the shaft to reduce the air gap, on axial movement of the shaft, to change the reluctance of the magnetic circuit and thereby induce a voltage in the coil. a detection coil wound around the first magnetic portion, the first magnetic portion comprising a permanent magnet or an electromagnet; wherein, the second portion is coupled to or moveable with the shaft to reduce the air gap, on axial movement of the shaft, to change the reluctance of the magnetic circuit and thereby induce a voltage in the coil.
A method for measuring clotting time comprising: mixing a blood specimen suspected to contain a lupus anticoagulant, an activator and a phospholipid; preparing a measurement sample by mixing a divalent-metal-ion-producing compound for facilitating formation of a phospholipid-containing complex and a mixture of the blood specimen, the activator and the phospholipid; and measuring a clotting time after adding, to the measurement sample, an aqueous solution of a calcium salt as a coagulation initiator; wherein the blood specimen, the activator and the phospholipid are incubated under a predetermined condition, and then the divalent-metal-ion-producing compound is mixed. mixing a blood specimen suspected to contain a lupus anticoagulant, an activator and a phospholipid; preparing a measurement sample by mixing a divalent-metal-ion-producing compound for facilitating formation of a phospholipid-containing complex and a mixture of the blood specimen, the activator and the phospholipid; and measuring a clotting time after adding, to the measurement sample, an aqueous solution of a calcium salt as a coagulation initiator; wherein the blood specimen, the activator and the phospholipid are incubated under a predetermined condition, and then the divalent-metal-ion-producing compound is mixed.
A device for dispensing a fluid product, comprising: - a fluid product dispenser comprising a reservoir containing fluid product and a dispensing means , such as a pump or a valve, mounted on said reservoir , - an internal body comprising a hollow cylinder receiving said dispenser , - an actuator provided with a dispensing orifice , mounted in order to be axially displaceable on said internal body between a rest position and an actuating position, the axial displacement of said actuator from its rest position to its actuating position actuating said dispensing means in order to dispense a dose of fluid product through said dispensing orifice , characterized in that said device comprises: - a motor , - an electronic control module , - a gear wheel connected to said motor and driven in rotation by said motor , and - a locking ring which is rotatably mounted on said internal body between a locking position and a release position, a spring urging said locking ring towards its locking position, said locking ring being displaced from its locking position towards its release position by said gear wheel , said locking ring cooperating in the locking position with said actuator in order to prevent its axial displacement and cooperating in the release position with said actuator in order to enable its axial displacement towards its actuating position. - a fluid product dispenser comprising a reservoir containing fluid product and a dispensing means , such as a pump or a valve, mounted on said reservoir , - an internal body comprising a hollow cylinder receiving said dispenser , - an actuator provided with a dispensing orifice , mounted in order to be axially displaceable on said internal body between a rest position and an actuating position, the axial displacement of said actuator from its rest position to its actuating position actuating said dispensing means in order to dispense a dose of fluid product through said dispensing orifice , - a motor , - an electronic control module , - a gear wheel connected to said motor and driven in rotation by said motor , and - a locking ring which is rotatably mounted on said internal body between a locking position and a release position, a spring urging said locking ring towards its locking position, said locking ring being displaced from its locking position towards its release position by said gear wheel , said locking ring cooperating in the locking position with said actuator in order to prevent its axial displacement and cooperating in the release position with said actuator in order to enable its axial displacement towards its actuating position.
An implantable lacrimal drug delivery device, comprising: a reservoir configured to hold a drug, the reservoir expandable between a relaxed state and an expanded state; a connector fluidly coupled to the reservoir, a lumen formed in the connector wherein the drug is configured to flow from the reservoir to a delivery site through the lumen and characterized in that the implantable lacrimal drug delivery device further comprises a hydrogel within the lumen, the hydrogel being configured to absorb the drug from the reservoir and deliver the drug from the lumen at the drug delivery site, the hydrogel including a first section which absorbs the drug at a first rate of absorption; and in that the connector includes a second lumen adapted to removably receive a delivery guide configured to implant the reservoir into a lacrimal sac of a patient. a reservoir configured to hold a drug, the reservoir expandable between a relaxed state and an expanded state; a connector fluidly coupled to the reservoir, a lumen formed in the connector wherein the drug is configured to flow from the reservoir to a delivery site through the lumen and characterized in that the implantable lacrimal drug delivery device further comprises a hydrogel within the lumen, the hydrogel being configured to absorb the drug from the reservoir and deliver the drug from the lumen at the drug delivery site, the hydrogel including a first section which absorbs the drug at a first rate of absorption; and in that the connector includes a second lumen adapted to removably receive a delivery guide configured to implant the reservoir into a lacrimal sac of a patient.